Nonhematologic adverse events observed in at least 3% of patients
| Parameter . | N (%) . | |||
|---|---|---|---|---|
| Decitabine (n = 73) . | Azacitidine (n = 40) . | |||
| All Grades . | Grade 3 . | All Grades . | Grade 3 . | |
| Nausea | 11 (15) | 0 | 6 (15) | 0 |
| Fatigue | 6 (8) | 0 | 4 (10) | 0 |
| Infection/Neutropenic fever | 5 (7) | 4 (5) | 2 (5) | 0 |
| Constipation | 3 (4) | 0 | 6 (15) | 0 |
| Diarrhea | 2 (3) | 0 | 3 (8) | 0 |
| Parameter . | N (%) . | |||
|---|---|---|---|---|
| Decitabine (n = 73) . | Azacitidine (n = 40) . | |||
| All Grades . | Grade 3 . | All Grades . | Grade 3 . | |
| Nausea | 11 (15) | 0 | 6 (15) | 0 |
| Fatigue | 6 (8) | 0 | 4 (10) | 0 |
| Infection/Neutropenic fever | 5 (7) | 4 (5) | 2 (5) | 0 |
| Constipation | 3 (4) | 0 | 6 (15) | 0 |
| Diarrhea | 2 (3) | 0 | 3 (8) | 0 |